Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| GlaxoSmithKline | 4.01% | $4.94M | $98.47B | 43.77% | 77 Outperform | |
| Reckitt Benckiser Group | 3.90% | $4.80M | $53.97B | 30.79% | 78 Outperform | |
| Orange SA | 3.90% | $4.79M | $42.71B | 59.30% | 63 Neutral | |
| Enel SpA Unsponsored ADR | 3.71% | $4.57M | $104.00B | 40.55% | 66 Neutral | |
| Royal KPN | 3.24% | $3.99M | $17.54B | 20.63% | 68 Neutral | |
| British American Tobacco | 3.23% | $3.98M | $123.19B | 51.66% | 59 Neutral | |
| Imperial Brands | 3.01% | $3.70M | $33.82B | 28.67% | 68 Neutral | |
| Wal-Mart de Mexico | 3.01% | $3.70M | $57.43B | 7.43% | 75 Outperform | |
| TSMC | 2.92% | $3.59M | $1.23T | 45.30% | 81 Outperform | |
| Petroleo Brasileiro SA- Petrobras | 2.89% | $3.55M | $76.65B | -10.51% | 69 Neutral |